Trade

Windlas Biotech share price

High risk
  • 56%Low risk
  • 56%Moderate risk
  • 56%Balanced risk
  • 56%High risk
  • 56%Extreme risk
  • ₹945.00(2.34%)
    July 16, 2025 15:29:23 PM IST
    • NSE
    • BSE
  • Vol : 30.68K (NSE + BSE)
    Last 20 day avg : 41.26 K

Windlas Biotech is trading 2.34% upper at Rs 945.00 as compared to its last closing price. Windlas Biotech has been trading in the price range of 945.00 & 927.00. Windlas Biotech has given -11.20% in this year & 3.58% in the last 5 days. Windlas Biotech has TTM P/E ratio 35.66 as compared to the sector P/E of 70.12.The company posted a net profit of 16.28 Crores in its last quarter.Listed peers of Windlas Biotech include Amrutanjan Health Care (-1.92%), Ttk Health Care (-1.62%), Windlas Biotech (2.34%).The Mutual Fund holding in Windlas Biotech was at 6.70% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Windlas Biotech was at 1.52% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 16, 2025, 12:08 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.64
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.73
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    31.21
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.72
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.06
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
927.00
Highest
945.00
52 week range
Lowest
656.25
Highest
1,197.00
Windlas Biotech News
Windlas Biotech Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in March quarter by 18.34% from Rs 202.70 crore to Rs 171.29 crore, year-on-year
    • financial-insightsThe company's profit declined by 4.19% year-on-year during the March quarter, dropping from Rs 16.99 crore to Rs 16.28 crore
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Windlas Biotech Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 927.17
  • R2
  • 964.48
  • R3
  • 993.42
Pivot898.23
  • S1
  • 860.92
  • S2
  • 831.98
  • S3
  • 794.67
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Windlas Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Amrutanjan Health Care
Neutral
707.25-1.922,074.2840.226.260.650.51
Ttk Health Care
Moderately Bullish
1,336.70-1.621,888.0826.961.80.740.17
Windlas Biotech
Moderately Bullish
945.002.341,964.6331.223.720.610.46
Syncom Formulations (india)
Moderately Bearish
18.86-0.261,770.0633.235.2--
Bliss Gvs Pharma
Bullish
157.902.271,664.9819.661.570.323.10
Windlas Biotech Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Windlas Biotech is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 62.34%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.03 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.41 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
    NA
    • Amount Invested (Cr.) 78.25
    • % of AUM 1.42
    UTI Healthcare Fund Regular Plan Growth
    NA
    • Amount Invested (Cr.) 13.80
    • % of AUM 1.30
    ICICI Prudential Smallcap Fund Institutional Growth
    3/5
    • Amount Invested (Cr.) 33.50
    • % of AUM 0.41
    ICICI Prudential Smallcap Fund Growth
    2/5
    • Amount Invested (Cr.) 33.50
    • % of AUM 0.41
    Bandhan BSE Healthcare Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 0.02
    • % of AUM 0.06
    Windlas Biotech Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-22Audited Results & Final Dividend
    2025-02-11Quarterly Results
    2024-11-12Quarterly Results
    2024-08-13Quarterly Results
    2024-05-20Audited Results & Dividend
    About the company Windlas Biotech
    • IndustryBiotechnology & Drugs
    • ISININE0H5O01029
    • BSE Code543329
    • NSE CodeWINDLAS
    Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.
    • Management Info
    No Data
    Management info for Windlas Biotech is currently unavailable
    Please check back later.
    Windlas Biotech Share Price FAQs

    Windlas Biotech is trading at 945.00 as on Wed Jul 16 2025 09:59:23. This is 2.34% upper as compared to its previous closing price of 923.40.

    The market capitalization of Windlas Biotech is 1964.63 Cr as on Wed Jul 16 2025 09:59:23.

    The 52 wk high for Windlas Biotech is 1197.00 whereas the 52 wk low is 656.25

    Windlas Biotech can be analyzed on the following key metrics -

    • TTM P/E: 35.66
    • Sector P/E: 70.12
    • Dividend Yield: 0.63%
    • D/E ratio: 0.06

    Windlas Biotech reported a net profit of 60.99 Cr in 2025.

    The Mutual Fund Shareholding was 6.70% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Windlas Biotech QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Windlas Biotech share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.